GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, SRC, THRA, THRB |
14.3606 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, SRC, THRA, THRB |
12.8674 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR1H4, NR3C1, PGR, PIM1, PPARA, RORC, SRC, THRA, THRB |
12.6049 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, ALPL, APEX1, AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, NR1H4, NR3C1, PPARA, RORC, SMAD3, SRC, TEK, TYR |
10.3551 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADRA2A, ADRA2C, AKR1B1, APEX1, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FLT3, GPER1, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TOP2A, XDH |
10.3543 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, THRA, THRB |
10.3364 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TOP2A, TYR, XDH |
10.1888 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, AR, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, GPER1, HSD17B2, IGF1R, INSR, MMP2, MMP9, NR1H4, NR3C1, PPARA, RORC, SRC, TEK, TYR |
10.1888 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, ALPL, APEX1, AR, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, GPER1, IGF1R, INSR, MMP2, NR1H4, NR3C1, PPARA, SMAD3, SRC, TEK |
10.0121 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP2, NR1H4, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TOP2A, TYR, XDH |
9.80803 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, ALPL, APEX1, AR, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, GPER1, INSR, NR3C1, PPARA, SRC, TEK |
9.51752 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADRA2A, ADRA2C, AKR1B1, APEX1, AR, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, CYP3A4, EGFR, ESR1, F10, FABP3, FABP4, FLT3, GPER1, GPR35, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, INSR, KDR, MET, MIF, NR1H4, PPARA, SMAD3, SRC, TEK, THRA, THRB, XDH |
9.31845 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADRA2A, ADRA2C, AKR1B1, APEX1, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GPER1, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TOP2A, XDH |
9.16077 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, THRA, THRB |
9.16077 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, GPER1, HSD17B2, NR1H4, NR3C1, RORC, SRC, TYR |
8.91327 |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, ALPL, APEX1, AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR1H4, NR3C1, PPARA, RORC, SMAD3, SRC, TEK, TYR |
8.82264 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, GPER1, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, NR1H4, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, THRA, TOP2A, XDH |
8.72569 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADRA2A, ADRA2C, AKR1B1, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, FLT3, GPER1, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, NR1H4, PTPN1, SMAD3, SRC, TEK, XDH |
8.69622 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, GPER1, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, NR1H4, PIM1, PTPN1, SMAD3, SRC, TEK, THRA, TOP2A, XDH |
8.68998 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADRA2A, ADRA2C, AKR1B1, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, FLT3, GPER1, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, NR1H4, PTPN1, SMAD3, SRC, TEK, XDH |
8.6807 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSD17B3, INSR, KDR, PPARA, SMAD3, SRC, TEK, THRA, TYR |
8.52134 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, NR1H4 |
8.31475 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADRA2A, AKR1B1, AR, CDC25B, CSNK2A1, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, NUAK1, PGR, PIM1, SMAD3, SRC, TEK, XDH |
8.05184 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, GPER1, HSPA1A, IGF1R, KDR, MIF, MMP9, NR1H4, PIM1, PTPN1, SMAD3, SRC, TEK, THRA, TOP2A, XDH |
8.05184 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, AR, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FLT3, GPER1, NR3C1, RORC, SRC, TEK, TYR |
8.04461 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADRA2A, ADRA2C, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, F10, FLT3, GPER1, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP9, NR1H4, NUAK1, PTPN1, SRC, TEK, XDH |
7.80368 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, FABP3, FUT7, GLO1, HSD17B3, HSPA1A, MIF, NR1H4, PIM1, PPARA, TYR, XDH |
7.61458 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, HSD17B2, HSD17B3, MET, MIF, NR1H4, PPARA |
7.61458 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AR, AURKB, AXL, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TOP2A, TYR, XDH |
7.61458 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADRA2A, ADRA2C, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, EGFR, ESR1, GPER1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, NR1H4 |
7.55318 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALPL, APEX1, AR, AXL, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR1H4, NR3C1, RORC, SMAD3, SRC |
7.43282 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
7.34277 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADRA2A, ADRA2C, AKR1B1, AR, AXL, CSNK2A1, CYP1B1, EGFR, F10, FLT3, GPER1, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, NR1H4, PTPN1, SMAD3, SRC, TEK, XDH |
7.28208 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALPL, APEX1, AR, AURKB, AXL, CA2, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B2, HSD17B3, INSR, KDR, MET, MIF, MMP2, MMP9, PGR, PIM1, PPARA, RORC, SMAD3, SRC, TEK, THRA, THRB, TOP2A, TYR |
7.2331 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADRA2A, ADRA2C, AR, AURKB, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR1H4, NR3C1, PGR, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TOP2A, XDH |
7.05844 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, NR1H4, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK |
7.0393 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2, HSD17B3 |
6.95621 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.95361 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALPL, APEX1, AR, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, MIF, MMP2, MMP9, NR1H4, NR3C1, NUAK1, PTPN1, RORC, SMAD3, SRC, TOP2A |
6.94783 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADRA2A, ADRA2C, AKR1B1, AR, AXL, CYP1B1, EGFR, F10, FLT3, GPER1, GPR35, HSPA1A, INSR, KDR, MET, MIF, PTPN1, SRC, TEK, XDH |
6.88187 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, NR1H4, PIM1, PTPN1, SMAD3, SRC, TEK |
6.88071 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALPL, APEX1, AR, AXL, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, GPER1, IGF1R, INSR, KDR, MMP2, NR1H4, NR3C1, RORC, SMAD3, SRC |
6.86159 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AR, AURKB, AXL, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TOP2A, TYR, XDH |
6.86159 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPER1, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR1H4, NUAK1, PTPN1, SMAD3, SRC, TEK, THRA, XDH |
6.79514 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADRA2A, ADRA2C, AKR1B1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPER1, GPR35, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR1H4, NR3C1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TOP2A, XDH |
6.72106 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADRA2A, ADRA2C, AR, AURKB, CDC25B, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR1H4, NR3C1, PGR, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TOP2A, XDH |
6.71947 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPER1, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR1H4, NUAK1, PTPN1, SMAD3, SRC, TEK, THRA, XDH |
6.67734 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADRA2A, ADRA2C, AR, AURKB, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR1H4, NR3C1, PGR, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TOP2A, XDH |
6.67734 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADRA2A, ADRA2C, AR, AURKB, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR1H4, NR3C1, PGR, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TOP2A, XDH |
6.49075 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADRA2A, ADRA2C, AKR1B1, AR, AXL, CSNK2A1, CYP1B1, EGFR, ESRRA, F10, FABP4, FLT3, GPER1, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP2, MMP9, NR1H4, PTPN1, SMAD3, SRC, TEK, XDH |
6.2533 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MIF, MMP9, NR1H4, PIM1, PTPN1, SMAD3, SRC, TEK |
6.215 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
6.04826 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
6.02122 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, AR, CDC25B, CSNK2A1, EGFR, ESR1, FLT3, GPER1, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, PIM1, TEK |
5.99735 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADRA2A, ADRA2C, AKR1B1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPER1, GPR35, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR1H4, NR3C1, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TOP2A, XDH |
5.99034 |
[BP] GO:0032501 |
multicellular organismal process
|
ADRA2A, ADRA2C, AKR1B1, AKR1B10, ALOX5, ALPL, AR, AXL, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRB, F10, FABP4, GPER1, HSD17B2, IGF1R, INSR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RORC, SMAD3, SRC, TEK, THRA, THRB, TYR |
5.95436 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.93572 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADRA2A, ADRA2C, AR, DUSP3, EGFR, ESR1, ESR2, GPER1, GPR35, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, NR1H4, PTPN1, SMAD3, SRC, XDH |
5.75611 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADRA2A, ADRA2C, APEX1, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, GPER1, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR1H4, PPARA, PTPN1, SMAD3, SRC, TEK, THRA |
5.74305 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADRA2A, ADRA2C, AR, DUSP3, EGFR, ESR1, ESR2, GPER1, GPR35, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, NR1H4, PTPN1, SMAD3, SRC, XDH |
5.74305 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, AR, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, GPER1, NR3C1, RORC, SRC |
5.7173 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSPA1A, IGF1R, INSR, MET, MMP12, NR1H4, NR3C1, PGR, PPARA, PTPN1, RORC, SMAD3, SRC, THRA, THRB, TOP2A |
5.6321 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADRA2A, ADRA2C, AR, CDC25B, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, GPER1, IGF1R, INSR, KDR, MIF, MMP9, NR1H4, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
5.55873 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADRA2A, ADRA2C, AR, CDC25B, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, GPER1, IGF1R, INSR, KDR, MIF, MMP9, NR1H4, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
5.49586 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADRA2A, ADRA2C, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPER1, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR1H4, NUAK1, PTPN1, SMAD3, SRC, TEK, THRA, XDH |
5.38909 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AR, AXL, CYP1B1, EGFR, ESR1, GPER1, IGF1R, INSR, MMP2, MMP9, NR1H4, NR3C1, RORC, SRC |
5.38512 |
[BP] GO:0022414 |
reproductive process
|
ADRA2C, AKR1B1, ALPL, AR, AXL, CDC25B, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD17B2, HSD17B3, INSR, MMP2, MMP9, PGR, SRC, THRA, THRB, TOP2A |
5.38191 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, GPER1, NR3C1, PGR, SRC |
5.38109 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADRA2A, ADRA2C, AR, CDC25B, EGFR, ESRRB, FABP3, FLT3, GPER1, INSR, KDR, MIF, MMP9, NR1H4, PTPN1, SMAD3, SRC, TEK, XDH |
5.38109 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADRA2A, ADRA2C, AR, CDC25B, EGFR, ESRRB, FABP3, FLT3, GPER1, INSR, KDR, MIF, MMP9, NR1H4, PTPN1, SMAD3, SRC, TEK, XDH |
5.38109 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADRA2A, ADRA2C, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, F10, FABP4, FLT3, GPER1, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP2, MMP9, NR1H4, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, THRA, XDH |
5.32735 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADRA2A, AKR1B1, ALPL, APEX1, AR, AURKB, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, F10, FABP3, FABP4, FLT3, GPER1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, NR1H4, NR3C1, NUAK1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, TOP2A, TYR |
5.28549 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, IGF1R, INSR, KDR, MET, MMP12, NR1H4, NR3C1, PGR, PPARA, RORC, SMAD3, SRC, THRA, THRB, TOP2A |
5.28549 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, IGF1R, INSR, KDR, MET, MMP12, NR1H4, NR3C1, PGR, PPARA, RORC, SMAD3, SRC, THRA, THRB, TOP2A |
5.28549 |
[BP] GO:0030334 |
regulation of cell migration
|
ADRA2A, APEX1, CYP19A1, CYP1B1, EGFR, F10, GPER1, IGF1R, INSR, KDR, MET, MIF, MMP9, SMAD3, SRC, TEK |
5.28549 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, HSD11B1, HSD17B1, HSD17B2, HSD17B3, TYR, XDH |
5.20573 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, APEX1, AR, EGFR, ESR1, FLT3, GPER1, IGF1R, INSR, MMP2, NR1H4, NR3C1, SMAD3, SRC |
5.16981 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.15413 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, TYR |
5.11683 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.10647 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALPL, AR, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSD17B3, INSR, KDR, MMP9, PGR, PIM1, PPARA, RORC, SMAD3, SRC, TEK, THRA, TYR |
5.05115 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADRA2A, ADRA2C, AR, EGFR, FLT3, GPER1, INSR, KDR, MIF, PTPN1, SRC, TEK, XDH |
4.97427 |
[BP] GO:2000145 |
regulation of cell motility
|
ADRA2A, APEX1, CYP19A1, CYP1B1, EGFR, F10, GPER1, IGF1R, INSR, KDR, MET, MIF, MMP9, SMAD3, SRC, TEK |
4.95497 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADRA2A, ADRA2C, AR, DUSP3, EGFR, FLT3, GPER1, IGF1R, INSR, KDR, MIF, PTPN1, SRC, TEK, XDH |
4.92613 |
[BP] GO:0080134 |
regulation of response to stress
|
ADRA2A, CYP19A1, DUSP3, EGFR, ESR1, FABP4, GPER1, HSPA1A, IGF1R, MET, MIF, MMP12, MMP2, NR1H4, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
4.92613 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADRA2A, APEX1, AR, AURKB, CSNK2A1, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GPER1, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR1H4, NR3C1, PGR, PPARA, PTPN1, RORC, SMAD3, SRC, THRA, THRB, XDH |
4.83312 |
[BP] GO:0051254 |
None
|
AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSPA1A, INSR, MET, MMP12, NR1H4, NR3C1, PGR, PPARA, RORC, SMAD3, SRC, THRA, THRB, TOP2A |
4.83312 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADRA2A, AR, CYP19A1, DUSP3, EGFR, ESR1, ESR2, GPER1, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, NR1H4, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
4.81694 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, IGF1R, INSR, MET, MMP12, NR1H4, NR3C1, PGR, PPARA, RORC, SMAD3, SRC, THRA, THRB, TOP2A |
4.81444 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, EGFR, F10, GPER1, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.77198 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, F10, GPER1, INSR, MET, SRC, TEK, XDH |
4.74563 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADRA2A, CYP1A1, FABP3, FLT3, GPER1, NR1H4, PPARA, RORC, SRC, TEK, THRA |
4.69766 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, EGFR, F10, GPER1, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.61573 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, SRC |
4.57854 |
[BP] GO:0051172 |
None
|
ADRA2A, APEX1, AR, AURKB, CSNK2A1, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GPER1, HSPA1A, IGF1R, MIF, MMP12, MMP9, NR1H4, NR3C1, PPARA, PTPN1, RORC, SMAD3, SRC, THRA, THRB, XDH |
4.54833 |
[BP] GO:0040012 |
regulation of locomotion
|
ADRA2A, APEX1, CYP19A1, CYP1B1, EGFR, F10, GPER1, IGF1R, INSR, KDR, MET, MIF, MMP9, SMAD3, SRC, TEK |
4.53837 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
4.53837 |
[BP] GO:0045893 |
None
|
AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, INSR, MET, MMP12, NR1H4, NR3C1, PGR, PPARA, RORC, SMAD3, SRC, THRA, THRB, TOP2A |
4.53293 |
[BP] GO:1903508 |
None
|
AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, INSR, MET, MMP12, NR1H4, NR3C1, PGR, PPARA, RORC, SMAD3, SRC, THRA, THRB, TOP2A |
4.53293 |
[BP] GO:1902680 |
None
|
AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, INSR, MET, MMP12, NR1H4, NR3C1, PGR, PPARA, RORC, SMAD3, SRC, THRA, THRB, TOP2A |
4.53293 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADRA2A, APEX1, CYP19A1, CYP1B1, EGFR, F10, GPER1, IGF1R, INSR, KDR, MET, MIF, MMP9, SMAD3, SRC, TEK |
4.53293 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, EGFR, F10, GPER1, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.52231 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APEX1, AR, AURKB, CSNK2A1, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GPER1, HSPA1A, IGF1R, KDR, MIF, MMP12, MMP9, NR1H4, NR3C1, PGR, PPARA, PTPN1, RORC, SMAD3, SRC, THRA, THRB, XDH |
4.51709 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADRA2A, ADRA2C, APEX1, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GPER1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR1H4, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TOP2A, XDH |
4.42159 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, EGFR, F10, GPER1, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.37009 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, AR, DUSP3, EGFR, ESR1, ESR2, GPER1, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, NR1H4, PTPN1, SMAD3, SRC, XDH |
4.32167 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SRC, TEK |
4.27305 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, HSD17B3, INSR, PGR, SRC |
4.27226 |
[BP] GO:0071383 |
None
|
AR, EGFR, FLT3, GPER1, NR3C1, SRC |
4.2582 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADRA2A, ADRA2C, APEX1, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GPER1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR1H4, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TOP2A, XDH |
4.23773 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADRA2A, ADRA2C, APEX1, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GPER1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR1H4, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TOP2A, XDH |
4.22797 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADRA2A, ADRA2C, APEX1, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, GLO1, GPER1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR1H4, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TOP2A, XDH |
4.19599 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADRA2A, ADRA2C, APEX1, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GPER1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR1H4, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TOP2A, XDH |
4.1686 |
[BP] GO:0042592 |
homeostatic process
|
ADRA2A, AKR1B1, APEX1, AXL, CA12, CA2, CA7, EGFR, ESR1, FABP3, FABP4, FLT3, GPER1, GPR35, INSR, MET, NR1H4, SMAD3, SRC |
4.14708 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADRA2A, ADRA2C, AR, CDC25B, DUSP3, EGFR, ESRRB, FABP4, FLT3, GPER1, IGF1R, INSR, KDR, MIF, MMP9, PPARA, PTPN1, SRC, TEK, XDH |
4.14708 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
4.14708 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DUSP3, ESR1, GPER1, HSPA1A, IGF1R, MET, MIF, MMP9, NR1H4, PTPN1, SRC, XDH |
4.13967 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, APEX1, AR, AURKB, CSNK2A1, DUSP3, ESR1, ESR2, ESRRA, FABP4, GPER1, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, NR1H4, NR3C1, PPARA, PTPN1, RORC, SMAD3, SRC, THRA, THRB, XDH |
4.0824 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, NR1H4, SRC, TEK |
4.0824 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
ADRA2A, APEX1, AR, EGFR, ESR1, FLT3, GPER1, INSR, NR3C1, SRC |
4.04732 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, ADRA2C, AR, AXL, CA2, CYP1B1, EGFR, ESRRB, GPER1, HSPA1A, KDR, MET, MIF, MMP12, MMP9, NR1H4, PIM1, SMAD3, SRC, TEK |
4.02997 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
4.01604 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADRA2A, ADRA2C, AR, CDC25B, EGFR, ESRRB, FLT3, GPER1, INSR, KDR, MIF, MMP9, PTPN1, SRC, TEK, XDH |
4.01604 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, EGFR, FABP3, FLT3, GPER1, IGF1R, INSR, MMP2, NR1H4, PPARA, SRC, TEK, TYR |
3.94408 |
[BP] GO:0007165 |
signal transduction
|
ADRA2A, ADRA2C, AKR1B1, AR, AXL, CA1, CA2, CSNK2A1, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GPR35, IGF1R, INSR, KDR, MET, MIF, MMP2, MMP9, NR1H4, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB |
3.93492 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, AR, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DAO, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
3.92803 |
[BP] GO:0071396 |
cellular response to lipid
|
AR, AXL, EGFR, ESR1, FLT3, GPER1, NR1H4, NR3C1, RORC, SRC |
3.92803 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.92078 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, CYP1A1, EGFR, ESR1, FLT3, MET, MIF, PIM1, SRC, TEK, TYR |
3.91666 |
[BP] GO:0045934 |
None
|
ADRA2A, APEX1, AR, AURKB, ESR1, ESR2, ESRRA, FABP4, GPER1, HSPA1A, MMP12, NR1H4, NR3C1, PPARA, RORC, SMAD3, SRC, THRA, THRB |
3.8748 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, EGFR, ESR1, PGR, PPARA, RORC, SRC, TOP2A |
3.80826 |
[BP] GO:0000122 |
None
|
AR, AURKB, ESR1, ESR2, ESRRA, HSPA1A, MMP12, NR1H4, NR3C1, PPARA, RORC, SMAD3, THRA, THRB |
3.80826 |
[BP] GO:0031347 |
regulation of defense response
|
CYP19A1, EGFR, ESR1, FABP4, GPER1, HSPA1A, MMP12, MMP2, NR1H4, PPARA, PTPN1, SMAD3, SRC, TEK |
3.79128 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, GPER1, INSR, MIF, SRC |
3.78684 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
3.78634 |
[BP] GO:0010676 |
None
|
ESRRB, GPER1, INSR, PPARA, SRC |
3.72122 |
[BP] GO:1903507 |
None
|
APEX1, AR, AURKB, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, NR1H4, NR3C1, PPARA, RORC, SMAD3, SRC, THRA, THRB |
3.70943 |
[BP] GO:1902679 |
None
|
APEX1, AR, AURKB, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, NR1H4, NR3C1, PPARA, RORC, SMAD3, SRC, THRA, THRB |
3.70375 |
[BP] GO:0010629 |
None
|
AR, AURKB, ESR1, ESR2, ESRRA, FABP4, GPER1, HSPA1A, KDR, MIF, MMP12, NR1H4, NR3C1, PGR, PPARA, RORC, SMAD3, SRC, THRA, THRB, XDH |
3.70375 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, CA2, EGFR, FLT3, GPER1, NR3C1, SRC |
3.6828 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F10, INSR, MET, SRC, TEK |
3.6828 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, AR, AXL, CDC25B, CYP1A1, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, GLO1, KDR, MET, MIF, MMP2, MMP9, PGR, RORC, SMAD3, SRC, TEK, THRA, THRB, TOP2A |
3.64949 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.64949 |
[BP] GO:0006357 |
None
|
AR, AURKB, CA9, EGFR, ESR1, ESR2, ESRRA, ESRRB, GLO1, GPER1, HSPA1A, MET, MMP12, NR1H4, NR3C1, PGR, PPARA, RORC, SMAD3, THRA, THRB, TOP2A |
3.62168 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, CA12, CA2, CA7, EGFR, ESR1, FABP3, FABP4, GPER1, GPR35, INSR, MET, NR1H4, SMAD3 |
3.61769 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, EGFR, FABP3, FLT3, GPER1, IGF1R, INSR, MMP2, NR1H4, PPARA, SRC, TEK, TYR |
3.61507 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADRA2A, ADRA2C, AR, CDC25B, EGFR, FLT3, GPER1, INSR, KDR, MIF, MMP9, PTPN1, SRC, TEK, XDH |
3.61105 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, APEX1, AR, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FLT3, FUT7, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TOP2A, TYR, XDH |
3.60061 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.59356 |
[BP] GO:0065009 |
regulation of molecular function
|
ADRA2A, ADRA2C, AR, AURKB, CDC25B, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FABP4, FLT3, GPER1, GPR35, HSPA1A, IGF1R, INSR, MET, MIF, MMP9, NR1H4, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
3.54596 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADRA2A, ADRA2C, AR, AXL, CA2, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, GPER1, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, NR1H4, PIM1, SMAD3, SRC, TEK, THRA, THRB, XDH |
3.53439 |
[BP] GO:0010628 |
positive regulation of gene expression
|
AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSPA1A, INSR, MET, MMP12, NR1H4, NR3C1, PGR, PPARA, RORC, SMAD3, SRC, THRA, THRB, TOP2A |
3.53439 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, FABP3, FABP4, FUT7, HSPA1A, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
3.53286 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FABP3, FABP4, FUT7, MET, MIF, PPARA |
3.52874 |
[BP] GO:0045944 |
None
|
AR, EGFR, ESR1, ESRRA, ESRRB, GPER1, MET, MMP12, NR1H4, NR3C1, PGR, PPARA, SMAD3, THRA, THRB, TOP2A |
3.52759 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADRA2A, ADRA2C, AR, CDC25B, DUSP3, EGFR, FABP4, FLT3, GPER1, IGF1R, INSR, KDR, MIF, MMP9, PTPN1, SRC, TEK, XDH |
3.52129 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
3.4612 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADRA2A, ADRA2C, AXL, CA2, CA7, CYP19A1, EGFR, GPER1, GPR35, HSPA1A, INSR, MIF, MMP12, MMP9, NR1H4, PPARA, PTPN1, SMAD3, SRC, THRA |
3.45616 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DAO, HSD17B3, NR1H4, TYR |
3.43112 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1, HSD17B3 |
3.41285 |
[BP] GO:0048732 |
gland development
|
AR, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, THRA, TYR |
3.41285 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, NR1H4, PPARA |
3.40054 |
[BP] GO:0031348 |
negative regulation of defense response
|
CYP19A1, GPER1, MMP12, NR1H4, PPARA, SMAD3, TEK |
3.39906 |
[BP] GO:0051253 |
None
|
APEX1, AR, AURKB, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, NR1H4, NR3C1, PPARA, RORC, SMAD3, SRC, THRA, THRB |
3.38548 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.35545 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, EGFR, HSPA1A |
3.34275 |
[BP] GO:0045892 |
None
|
AR, AURKB, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, NR1H4, NR3C1, PPARA, RORC, SMAD3, SRC, THRA, THRB |
3.34275 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, NR1H4, SRC, TEK, TOP2A |
3.33637 |
[BP] GO:0001503 |
ossification
|
ALPL, EGFR, MMP2, MMP9, TEK, THRA |
3.3328 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADRA2A, ADRA2C, AR, AURKB, CDC25B, EGFR, ESR1, ESR2, FLT3, GPER1, HSPA1A, INSR, MET, MIF, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
3.31486 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
CYP19A1, GPER1, NR1H4, PPARA, SMAD3, TEK |
3.31486 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, EGFR, NR3C1, SRC |
3.30875 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADRA2A, DUSP3, EGFR, FLT3, IGF1R, INSR, MIF, PTPN1, SRC |
3.27943 |
[BP] GO:0045913 |
None
|
ESRRB, GPER1, INSR, PPARA, SRC |
3.23825 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADRA2A, AURKB, CSNK2A1, CYP1B1, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, MMP9, NR1H4, PIM1, PPARA, PTPN1, SRC |
3.23643 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADRA2A, ADRA2C, AR, CDC25B, DUSP3, EGFR, FABP4, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PTPN1, SRC, TEK, XDH |
3.2297 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.22521 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1, HSD17B3 |
3.21666 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADRA2A, ADRA2C, AR, CDC25B, CSNK2A1, EGFR, ESR1, FLT3, GPER1, HSPA1A, INSR, KDR, MIF, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
3.20933 |
[BP] GO:0010675 |
None
|
ESRRB, GPER1, INSR, PPARA, RORC, SRC |
3.20684 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, FABP3, GPER1, IGF1R, INSR, PPARA, SRC, TEK |
3.2054 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
CYP19A1, EGFR, ESR1, FABP4, GPER1, KDR, MET, MIF, MMP12, NR1H4, PPARA, SMAD3, TEK |
3.19048 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2, HSD17B3, MIF |
3.1902 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.17905 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, NR1H4, PPARA, SRC, TEK |
3.17905 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADRA2A, ADRA2C, AR, AURKB, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, FLT3, GPER1, HSPA1A, IGF1R, INSR, MIF, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
3.16075 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APEX1, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPN1, SRC, TEK, XDH |
3.15753 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, NR1H4, SRC, TEK |
3.14798 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
3.14612 |
[BP] GO:0032148 |
None
|
ADRA2A, ADRA2C, INSR, SRC |
3.1361 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, CYP19A1, ESR1, HSD17B2, HSD17B3, INSR, SRC |
3.13455 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.11999 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADRA2A, ADRA2C, AKR1B1, APEX1, AR, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GLO1, GPER1, GPR35, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TOP2A, XDH |
3.10033 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
DUSP3, EGFR, GPER1, KDR, MIF, PTPN1, SRC, TEK |
3.0952 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, CDC25B, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.0734 |
[BP] GO:0090087 |
None
|
ACHE, ADRA2A, ADRA2C, CA2, EGFR, GPER1, MIF, MMP12, NR1H4, PTPN1, SMAD3, SRC, THRA |
3.05264 |
[BP] GO:0009890 |
None
|
ADRA2A, APEX1, AR, AURKB, ESR1, ESR2, ESRRA, FABP4, GPER1, HSPA1A, MMP12, NR1H4, NR3C1, PPARA, RORC, SMAD3, SRC, THRA, THRB |
3.05077 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
3.01495 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, KDR, NR3C1, SRC |
3.01495 |
[BP] GO:0045742 |
None
|
ADRA2A, ADRA2C, GPER1, MMP9 |
3.00764 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADRA2A, AURKB, CA2, CA7, EGFR, GPER1, KDR, MIF, NR1H4, SRC |
3.00389 |
[BP] GO:0019219 |
regulation of nucleobase-containing compound metabolic process
|
ADRA2A, APEX1, AR, AURKB, CA9, CSNK2A1, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, GPER1, HSPA1A, IGF1R, INSR, MET, MMP12, NR1H4, NR3C1, NR3C2, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, THRA, THRB, TOP2A |
3.00381 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADRA2A, ADRA2C, AR, CDC25B, EGFR, ESR1, FLT3, GPER1, HSPA1A, INSR, KDR, MIF, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
2.9992 |
[BP] GO:0048806 |
genitalia development
|
AXL, CYP19A1, ESR1, HSD17B3 |
2.97087 |
[BP] GO:0006355 |
regulation of transcription, DNA-templated
|
APEX1, AR, AURKB, CA9, CSNK2A1, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, GPER1, HSPA1A, INSR, MET, MMP12, NR1H4, NR3C1, NR3C2, PGR, PIM1, PPARA, RORC, SMAD3, SRC, THRA, THRB, TOP2A |
2.94319 |
[BP] GO:1901655 |
None
|
AKR1B1, AR, EGFR, NR3C1, SRC |
2.94042 |
[BP] GO:1901186 |
None
|
ADRA2A, ADRA2C, GPER1, MMP9 |
2.93644 |
[BP] GO:0008050 |
None
|
THRA, THRB |
2.93644 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.93644 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.93014 |
[BP] GO:1903506 |
regulation of nucleic acid-templated transcription
|
APEX1, AR, AURKB, CA9, CSNK2A1, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, GPER1, HSPA1A, INSR, MET, MMP12, NR1H4, NR3C1, NR3C2, PGR, PIM1, PPARA, RORC, SMAD3, SRC, THRA, THRB, TOP2A |
2.93014 |
[BP] GO:2001141 |
regulation of RNA biosynthetic process
|
APEX1, AR, AURKB, CA9, CSNK2A1, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, GPER1, HSPA1A, INSR, MET, MMP12, NR1H4, NR3C1, NR3C2, PGR, PIM1, PPARA, RORC, SMAD3, SRC, THRA, THRB, TOP2A |
2.92057 |
[BP] GO:0050727 |
regulation of inflammatory response
|
CYP19A1, EGFR, ESR1, FABP4, GPER1, NR1H4, PPARA, SMAD3, TEK |
2.91457 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APEX1, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPN1, SRC, TEK, XDH |
2.91373 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADRA2A, ADRA2C, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MIF, PTPN1, SRC, TEK |
2.89448 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, EGFR, GPER1, IGF1R, INSR, MMP2, NR1H4, SRC |
2.85945 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GLO1, GPER1, GPR35, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TOP2A, TYR, XDH |
2.85097 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.84375 |
[BP] GO:0042058 |
None
|
ADRA2A, ADRA2C, EGFR, GPER1, MMP9 |
2.84245 |
[BP] GO:0050793 |
regulation of developmental process
|
ADRA2C, AR, AXL, CA2, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, GPER1, INSR, KDR, MIF, NR1H4, NUAK1, PIM1, PPARA, RORC, SMAD3, SRC, TEK, THRA, XDH |
2.79719 |
[BP] GO:0009889 |
regulation of biosynthetic process
|
ADRA2A, APEX1, AR, AURKB, CA9, CSNK2A1, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPER1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NR1H4, NR3C1, NR3C2, PGR, PIM1, PPARA, RORC, SMAD3, SRC, THRA, THRB, TOP2A |
2.77553 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADRA2A, ADRA2C, AURKB, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MIF, PTPN1, SRC, TEK |
2.74914 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, AURKB, CDC25B, CSNK2A1, CYP1A1, DUSP3, EGFR, GPER1, HSPA1A, INSR, MIF, PIM1, SMAD3, SRC, TOP2A |
2.70666 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, EGFR, FLT3, GPER1, NR3C1, SRC |
2.70307 |
[BP] GO:0003018 |
None
|
ADRA2A, ADRA2C, EGFR, GPER1, SRC, TEK |
2.70307 |
[BP] GO:0050730 |
None
|
ADRA2A, ADRA2C, EGFR, FLT3, MIF, PTPN1, SRC |
2.70219 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, ADRA2A, ADRA2C, AR, CSNK2A1, EGFR, GPER1, MIF, MMP12, NR1H4, PTPN1, SMAD3, SRC, THRA |
2.69868 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
AR, AURKB, AXL, ESR1, GPER1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK |
2.69404 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.6848 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, NR1H4, SRC |
2.67589 |
[BP] GO:0050714 |
None
|
ACHE, EGFR, GPER1, MIF, MMP12, NR1H4, SRC |
2.66288 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
HSPA1A, MIF, MMP9, PTPN1, SRC |
2.66288 |
[BP] GO:0050708 |
None
|
ACHE, ADRA2A, ADRA2C, EGFR, GPER1, MIF, MMP12, NR1H4, SRC |
2.6554 |
[BP] GO:0010906 |
None
|
ESRRB, INSR, PPARA, RORC, SRC |
2.64382 |
[BP] GO:0031327 |
None
|
ADRA2A, APEX1, AR, AURKB, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, NR1H4, NR3C1, PPARA, RORC, SMAD3, SRC, THRA, THRB |
2.63466 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, EGFR, GPER1, IGF1R, INSR, MMP2, NR1H4, SRC |
2.62789 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, MIF |
2.62784 |
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, FLT3, GPER1, KDR, TEK |
2.62784 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, DAO, HSD17B3, TYR |
2.61697 |
[BP] GO:0050678 |
None
|
AR, EGFR, KDR, MMP12, PGR, SMAD3, TEK, XDH |
2.61597 |
[BP] GO:0051223 |
None
|
ACHE, ADRA2A, ADRA2C, EGFR, GPER1, MIF, MMP12, NR1H4, PTPN1, SMAD3, SRC, THRA |
2.61083 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADRA2A, APEX1, CSNK2A1, EGFR, ESRRB, HSPA1A, INSR, KDR, MET, PPARA, PTPN1, SMAD3, THRA |
2.60874 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TOP2A |
2.60651 |
[BP] GO:1901184 |
None
|
ADRA2A, ADRA2C, EGFR, GPER1, MMP9 |
2.59499 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, NR1H4, PPARA |
2.58857 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADRA2A, ADRA2C, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MIF, PTPN1, SRC |
2.58163 |
[BP] GO:0000904 |
cell morphogenesis involved in differentiation
|
AR, AXL, MET, SRC, TEK |
2.57814 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADRA2A, ADRA2C, CDC25B, EGFR, FLT3, INSR, MIF, PTPN1, SRC, TEK |
2.57258 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADRA2A, ADRA2C, AR, CDC25B, EGFR, FLT3, GPER1, INSR, KDR, MIF, MMP9, PTPN1, SRC, TEK, XDH |
2.57084 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, AR, AXL, CYP1A1, EGFR, ESR1, PGR, SRC, THRA, THRB |
2.5669 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.5669 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.5669 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.5669 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.5669 |
[BP] GO:0031326 |
regulation of cellular biosynthetic process
|
ADRA2A, APEX1, AR, AURKB, CA9, CSNK2A1, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPER1, HSPA1A, IGF1R, INSR, MET, MMP12, NR1H4, NR3C1, NR3C2, PGR, PIM1, PPARA, RORC, SMAD3, SRC, THRA, THRB, TOP2A |
2.55971 |
[BP] GO:0060748 |
None
|
AR, PGR |
2.55302 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.55302 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.55302 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.52732 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, MIF |
2.51654 |
[BP] GO:0051252 |
regulation of RNA metabolic process
|
APEX1, AR, AURKB, CA9, CSNK2A1, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, GPER1, HSPA1A, INSR, MET, MMP12, NR1H4, NR3C1, NR3C2, PGR, PIM1, PPARA, RORC, SMAD3, SRC, THRA, THRB, TOP2A |
2.51652 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADRA2A, ADRA2C, FLT3, MIF, PTPN1, SRC |
2.49276 |
[BP] GO:0002793 |
None
|
ACHE, EGFR, GPER1, MIF, MMP12, NR1H4, SRC |
2.49179 |
[BP] GO:0010468 |
regulation of gene expression
|
APEX1, AR, AURKB, CA9, CSNK2A1, CYP1A2, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, GPER1, HSPA1A, INSR, KDR, MET, MIF, MMP12, NR1H4, NR3C1, NR3C2, PGR, PIM1, PPARA, RORC, SMAD3, SRC, THRA, THRB, TOP2A, XDH |
2.49179 |
[BP] GO:0002791 |
None
|
ACHE, ADRA2A, ADRA2C, EGFR, GPER1, MIF, MMP12, NR1H4, SRC |
2.49179 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADRA2A, ADRA2C, AURKB, CDC25B, EGFR, FLT3, INSR, MIF, PTPN1, SRC, TEK |
2.49179 |
[BP] GO:0006109 |
regulation of carbohydrate metabolic process
|
ESRRB, GPER1, INSR, PPARA, RORC, SRC |
2.48915 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.4846 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.4846 |
[BP] GO:0010556 |
regulation of macromolecule biosynthetic process
|
APEX1, AR, AURKB, CA9, CSNK2A1, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, GPER1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NR1H4, NR3C1, NR3C2, PGR, PIM1, PPARA, RORC, SMAD3, SRC, THRA, THRB, TOP2A |
2.46189 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, SRC |
2.45864 |
[BP] GO:0048729 |
tissue morphogenesis
|
AR, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.44624 |
[BP] GO:0001775 |
cell activation
|
ADRA2A, ADRA2C, ALOX5, AXL, EGFR, FLT3, FUT7, HSPA1A, MIF, MMP9, RORC, SMAD3, SRC |
2.44624 |
[BP] GO:0070201 |
None
|
ACHE, ADRA2A, ADRA2C, EGFR, GPER1, MIF, MMP12, NR1H4, PTPN1, SMAD3, SRC, THRA |
2.4457 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, EGFR, GPER1, MIF, MMP12, NR1H4, SRC |
2.44058 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADRA2A, AXL, CA2, CYP19A1, EGFR, GPER1, INSR, MIF, MMP12, NR1H4, SMAD3, SRC |
2.43156 |
[BP] GO:0009058 |
None
|
ACHE, AKR1B1, ALOX5, APEX1, AR, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSD11B1, HSD17B1, HSD17B2, HSD17B3, MIF, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, SMAD3, THRA, THRB, TYR |
2.42643 |
[BP] GO:0010558 |
None
|
APEX1, AR, AURKB, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, NR1H4, NR3C1, PPARA, RORC, SMAD3, SRC, THRA, THRB |
2.42479 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADRA2A, EGFR, FLT3, INSR, MIF, PTPN1, SRC |
2.42016 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.41038 |
[BP] GO:0051094 |
positive regulation of developmental process
|
ADRA2C, AR, AXL, CA2, CYP1B1, ESRRB, GPER1, INSR, KDR, NR1H4, PIM1, SMAD3, SRC, TEK, THRA |
2.40714 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.40031 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADRA2A, ADRA2C, AURKB, CDC25B, EGFR, ESR1, FLT3, GPER1, HSPA1A, INSR, MIF, PTPN1, SMAD3, SRC, TEK, XDH |
2.39354 |
[BP] GO:1901360 |
None
|
ACHE, AKR1B1, AKR1B10, AOX1, APEX1, AR, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, ESR1, ESR2, ESRRA, ESRRB, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, SMAD3, THRA, THRB, TOP2A, TYR, XDH |
2.38559 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, RORC |
2.36731 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
2.36731 |
[BP] GO:0070988 |
demethylation
|
APEX1, CYP1A1, CYP1A2, CYP3A4 |
2.35976 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.34621 |
[BP] GO:0071384 |
None
|
EGFR, FLT3, GPER1, NR3C1 |
2.33606 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, MIF, NR1H4, PPARA |
2.33606 |
[BP] GO:0044249 |
None
|
ACHE, AKR1B1, ALOX5, APEX1, AR, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSD17B1, HSD17B2, HSD17B3, MIF, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, SMAD3, THRA, THRB, TYR |
2.31851 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.3181 |
[BP] GO:0035625 |
None
|
ADRA2A, ADRA2C |
2.3181 |
[BP] GO:0032811 |
None
|
ADRA2A, ADRA2C |
2.3181 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.3181 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.3181 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.3181 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, DAO, FABP3, GLO1, MIF, NR1H4, PIM1, PPARA, TYR |
2.31265 |
[BP] GO:0043434 |
None
|
APEX1, FABP3, GPER1, INSR, PPARA, SRC, TEK |
2.31124 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.30754 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
CYP19A1, GPER1, MIF, NR1H4, PPARA, SMAD3, TEK |
2.30376 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, AURKB, CA2, CYP1A1, EGFR, HSPA1A, MMP2, PPARA, SMAD3, SRC, TEK, THRA, TYR |
2.29434 |
[BP] GO:2000112 |
regulation of cellular macromolecule biosynthetic process
|
APEX1, AR, AURKB, CA9, CSNK2A1, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, GPER1, HSPA1A, IGF1R, INSR, MET, MMP12, NR1H4, NR3C1, NR3C2, PGR, PIM1, PPARA, RORC, SMAD3, SRC, THRA, THRB, TOP2A |
2.29434 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.29072 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, CDC25B, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.28248 |
[BP] GO:2001233 |
regulation of apoptotic signaling pathway
|
AR, GPER1, HSPA1A, MIF, MMP9, PTPN1, SMAD3, SRC |
2.28209 |
[BP] GO:0051047 |
None
|
ACHE, CYP19A1, EGFR, GPER1, MIF, MMP12, NR1H4, SRC |
2.27734 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, CA9, CYP1A1, CYP1B1, EGFR, FABP3, KDR, NR3C1, SRC |
2.27734 |
[BP] GO:0051128 |
regulation of cellular component organization
|
AR, AURKB, AXL, CSNK2A1, EGFR, ESR1, ESR2, GPER1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PTPN1, SMAD3, SRC, TEK, THRA, TOP2A |
2.26661 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.26518 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.26518 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
EGFR, GPER1, KDR, MIF, SRC, TEK |
2.25924 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
AURKB, GPER1, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
2.25055 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, GPER1 |
2.23675 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.23675 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, SRC, TEK |
2.22442 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADRA2A, ADRA2C, AR, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
2.22442 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADRA2A, DUSP3, EGFR, FLT3, IGF1R, INSR, MIF, PTPN1, SRC |
2.21621 |
[BP] GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling
|
FLT3, GPER1, KDR, TEK |
2.21621 |
[BP] GO:1900076 |
regulation of cellular response to insulin stimulus
|
ESRRA, NR1H4, PTPN1, SRC |
2.19178 |
[BP] GO:2000113 |
None
|
AR, AURKB, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, NR1H4, NR3C1, PPARA, RORC, SMAD3, SRC, THRA, THRB |
2.18524 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, GPER1, MMP2, MMP9 |
2.18131 |
[BP] GO:0003013 |
None
|
ADRA2A, ADRA2C, EGFR, GPER1, SRC, TEK |
2.1774 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.17488 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.17488 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, MIF, PPARA |
2.17461 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, GPER1, MMP9, SMAD3, SRC, XDH |
2.17174 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADRA2A, ADRA2C, CDC25B, EGFR, FLT3, INSR, MIF, PTPN1, SRC |
2.158 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, CYP1A1, CYP1B1, KDR, SRC |
2.15341 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, GPER1, IGF1R, INSR, SRC |
2.15341 |
[BP] GO:0035624 |
None
|
ADRA2A, ADRA2C |
2.14682 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
CYP19A1, HSD17B3 |
2.14682 |
[BP] GO:0060509 |
None
|
THRA, THRB |
2.14682 |
[BP] GO:0014060 |
None
|
ADRA2A, ADRA2C |
2.14682 |
[BP] GO:0030263 |
None
|
GPER1, TOP2A |
2.14682 |
[BP] GO:1900078 |
None
|
ESRRA, NR1H4, SRC |
2.14146 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, HSPA1A, MIF, MMP9, PTPN1, SRC |
2.12871 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA2A, ADRA2C, AKR1B1, AXL, CYP1B1, EGFR, GPER1, IGF1R, INSR, KDR, MET, MIF, NUAK1, PTPN1, SRC, TEK |
2.1058 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.07279 |
[BP] GO:1901362 |
None
|
AKR1B1, APEX1, AR, CSNK2A1, CYP19A1, CYP3A4, DAO, ESR1, ESR2, ESRRA, ESRRB, HSD11B1, HSD17B1, HSD17B2, HSD17B3, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, SMAD3, THRA, THRB, TYR |
2.05175 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, AR, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, TOP2A |
2.04647 |
[BP] GO:0035265 |
organ growth
|
AR, CYP19A1, ESR1 |
2.01404 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.01404 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.01404 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.01404 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9 |
2.01404 |
[CC] GO:0005654 |
None
|
AKR1B1, ALOX5, APEX1, AR, AURKB, CDC25B, CSNK2A1, DUSP3, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, MIF, NR1H4, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, RORC, SMAD3, SRC, THRA, THRB, TOP2A |
3.01495 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADRA2C, AKR1B1, AKR1B10, ALPL, AOX1, APEX1, AR, AURKB, AXL, CA1, CA2, CA4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, GPER1, HSD17B3, HSPA1A, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTPN1, RORC, SHBG, SMAD3, SRC, THRA, THRB, TOP2A, TYR, XDH |
2.66288 |
[CC] GO:0044428 |
nuclear part
|
AKR1B1, ALOX5, AOX1, APEX1, AR, AURKB, CA9, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSPA1A, INSR, MIF, NR1H4, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, RORC, SMAD3, SRC, THRA, THRB, TOP2A |
2.49188 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADRA2C, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AR, AURKB, CA1, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DUSP3, EGFR, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, GLO1, GPER1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, INSR, KDR, MIF, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PTPN1, SMAD3, SRC, THRA, TOP2A, TYR, XDH |
2.49179 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADRA2A, CA2, CA4, CA9, EGFR, TEK |
2.35919 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, AR, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, NR3C2, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, THRA, THRB, TYR, XDH |
21.0479 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, THRA, THRB |
17.3876 |
[MF] GO:0005496 |
steroid binding
|
AR, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSD17B1, NR1H4, NR3C1, NR3C2, PGR, RORC, SHBG |
15.0642 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR1H4, PGR, PPARA, RORC, THRA, THRB |
14.9277 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR1H4, PGR, PPARA, RORC, THRA, THRB |
14.9277 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GLO1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TOP2A, TYR, XDH |
13.6907 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, NR3C2, PGR, PPARA, PTPN1, RORC, SMAD3, THRA, THRB |
13.6907 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, EGFR, GPER1, HSD17B1, IGF1R, INSR, NR3C1, SHBG, THRA, THRB |
10.4606 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.1809 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DUSP3, EGFR, F10, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK, TOP2A, TYR, XDH |
8.98665 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, THRA, THRB, TOP2A, TYR, XDH |
8.94038 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APEX1, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, THRA, THRB, TOP2A, TYR, XDH |
8.65948 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, GPER1, HSD17B1, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, SHBG |
8.52117 |
[MF] GO:0038023 |
signaling receptor activity
|
ADRA2A, ADRA2C, AR, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GPR35, IGF1R, INSR, KDR, MET, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, TEK, THRA, THRB |
8.06762 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.41876 |
[MF] GO:0004872 |
receptor activity
|
ADRA2A, ADRA2C, AR, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GPR35, IGF1R, INSR, KDR, MET, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, TEK, THRA, THRB |
7.07761 |
[MF] GO:0004871 |
signal transducer activity
|
ADRA2A, ADRA2C, AR, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GPR35, IGF1R, INSR, KDR, MET, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, SMAD3, TEK, THRA, THRB |
6.96672 |
[MF] GO:0060089 |
molecular transducer activity
|
ADRA2A, ADRA2C, AR, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GPR35, IGF1R, INSR, KDR, MET, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, TEK, THRA, THRB |
6.86159 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.86159 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.71029 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, HSD11B1, HSD17B1, HSD17B2, HSD17B3, TYR, XDH |
6.38438 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.3549 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADRA2A, APEX1, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC, THRA |
5.34393 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.30926 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.2395 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
5.18629 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADRA2A, APEX1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, SMAD3, SRC, THRA |
5.14936 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.07766 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, XDH |
5.05115 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
4.55591 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADRA2A, ADRA2C, AOX1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NR1H4, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RORC, SHBG, SMAD3, SRC, TEK, THRA, THRB, TOP2A, XDH |
4.5235 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SRC, TEK, TOP2A |
4.44607 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2, GPER1 |
4.12627 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
3.99547 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, AR, AURKB, CDC25B, CYP1A1, CYP1A2, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRB, HSPA1A, MET, MIF, NR3C1, PGR, PPARA, PTPN1, SMAD3, SRC, TEK, THRB, TOP2A |
3.95428 |
[MF] GO:0000981 |
None
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR1H4, NR3C1, PGR, PPARA, RORC, SMAD3, THRA, THRB |
3.94408 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.92078 |
[MF] GO:0043565 |
None
|
APEX1, AR, ESR1, ESR2, ESRRA, ESRRB, MMP12, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, SMAD3, THRA, THRB |
3.73601 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
3.70943 |
[MF] GO:0004887 |
None
|
NR1H4, THRA, THRB |
3.66615 |
[MF] GO:0003690 |
None
|
APEX1, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, NR1H4, NR3C1, PGR, PPARA, RORC, SMAD3, THRA |
3.59356 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
3.46952 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
3.3599 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.35284 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.35284 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
3.23693 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, ADRA2C, AOX1, CSNK2A1, EGFR, ESR1, ESR2, FLT3, IGF1R, KDR, MET, MIF, MMP9, PGR, SMAD3, TOP2A, TYR, XDH |
3.1902 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.1902 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.096 |
[MF] GO:1901363 |
heterocyclic compound binding
|
AOX1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NR1H4, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TOP2A, XDH |
2.99173 |
[MF] GO:0008134 |
transcription factor binding
|
APEX1, AR, ESR1, ESRRB, FLT3, NR1H4, PIM1, PPARA, SMAD3, SRC, THRA |
2.97087 |
[MF] GO:0000976 |
None
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR1H4, NR3C1, PGR, PPARA, RORC, SMAD3, THRA |
2.95696 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, HSD17B1, SRC, XDH |
2.95303 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
2.94042 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.93644 |
[MF] GO:0044212 |
None
|
AR, ESR1, ESR2, ESRRA, ESRRB, MMP12, NR1H4, NR3C1, PGR, PPARA, RORC, SMAD3, THRA |
2.93206 |
[MF] GO:0001067 |
None
|
AR, ESR1, ESR2, ESRRA, ESRRB, MMP12, NR1H4, NR3C1, PGR, PPARA, RORC, SMAD3, THRA |
2.93014 |
[MF] GO:0000978 |
None
|
AR, ESR1, ESR2, ESRRA, NR3C1, PGR, PPARA, RORC, SMAD3 |
2.86657 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.85633 |
[MF] GO:1990837 |
None
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR1H4, NR3C1, PGR, PPARA, RORC, SMAD3, THRA |
2.78258 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.75994 |
[MF] GO:0001012 |
None
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR1H4, NR3C1, PGR, PPARA, RORC, SMAD3 |
2.75994 |
[MF] GO:0000977 |
None
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR1H4, NR3C1, PGR, PPARA, RORC, SMAD3 |
2.75994 |
[MF] GO:0000987 |
None
|
AR, ESR1, ESR2, ESRRA, NR3C1, PGR, PPARA, RORC, SMAD3 |
2.73382 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
2.70307 |
[MF] GO:0019900 |
None
|
ADRA2A, AURKB, CDC25B, DUSP3, EGFR, ESR1, NR3C1, PTPN1, SMAD3, SRC, TOP2A |
2.60651 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.55302 |
[MF] GO:0004938 |
None
|
ADRA2A, ADRA2C |
2.55302 |
[MF] GO:0005102 |
receptor binding
|
ADRA2A, ADRA2C, AR, DAO, EGFR, ESR1, ESR2, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, NR1H4, PTPN1, SMAD3, SRC |
2.49179 |
[MF] GO:0003700 |
None
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, SMAD3, THRA, THRB |
2.45864 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.45864 |
[MF] GO:0019901 |
None
|
ADRA2A, CDC25B, DUSP3, EGFR, ESR1, NR3C1, PTPN1, SMAD3, SRC, TOP2A |
2.42643 |
[MF] GO:0036094 |
small molecule binding
|
AOX1, AURKB, AXL, CSNK2A1, DAO, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NR1H4, NUAK1, PIM1, SRC, TEK, TOP2A, XDH |
2.42509 |
[MF] GO:0001077 |
None
|
AR, ESR1, ESRRA, NR1H4, NR3C1, PGR, PPARA |
2.34199 |
[MF] GO:0140110 |
None
|
APEX1, AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSPA1A, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, SMAD3, THRA, THRB |
2.3181 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.3181 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.3181 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.3181 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.3181 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.27892 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.26833 |
[MF] GO:0003682 |
None
|
APEX1, AR, EGFR, ESR1, GPER1, SMAD3, THRA, THRB, TOP2A |
2.225 |
[MF] GO:0043168 |
anion binding
|
AOX1, AURKB, AXL, CSNK2A1, DAO, EGFR, F10, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NR1H4, NUAK1, PIM1, SRC, TEK, TOP2A, XDH |
2.17174 |
[MF] GO:0000982 |
None
|
AR, ESR1, ESRRA, NR1H4, NR3C1, PGR, PPARA, RORC |
2.17174 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.15806 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.14682 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.14682 |
[MF] GO:0001228 |
None
|
AR, ESR1, ESRRA, ESRRB, NR1H4, NR3C1, PGR, PPARA |
2.1124 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.05221 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK |
2.01868 |